Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Normothermic Perfusion of Isolated Organs Market Size Growth Rate by Type (2026-2032)
1.2.2 Heart Perfusion
1.2.3 Liver Perfusion
1.2.4 Kidney Perfusion
1.2.5 Lung Perfusion
1.3 Market by Application
1.3.1 Global Normothermic Perfusion of Isolated Organs Market Share by Application (2026-2032)
1.3.2 Organ Transplant Specialist Hospitals
1.3.3 Organ Banks
1.3.4 Pharmaceutical Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Normothermic Perfusion of Isolated Organs Market Size
2.2 Normothermic Perfusion of Isolated Organs Market Size by Region
2.2.1 Normothermic Perfusion of Isolated Organs Growth Rate by Region (2026-2032)
2.2.2 Normothermic Perfusion of Isolated Organs Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Normothermic Perfusion of Isolated Organs Revenue by Players (2026 & 2032)
3.2 Normothermic Perfusion of Isolated Organs Key Players Headquarters and Area Served
3.3 Key Players Normothermic Perfusion of Isolated Organs Product/Solution/Service
3.4 Date of Enter into Normothermic Perfusion of Isolated Organs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Normothermic Perfusion of Isolated Organs Market Size by Type (2026-2032)
4.2 Global Normothermic Perfusion of Isolated Organs Market Size by Application (2026-2032)
5 North America
5.1 North America Normothermic Perfusion of Isolated Organs Market Forecast (2026-2032)
5.2 Normothermic Perfusion of Isolated Organs Key Players in North America
5.3 North America Normothermic Perfusion of Isolated Organs Market Size by Type
5.4 North America Normothermic Perfusion of Isolated Organs Market Size by Application
6 Europe
6.1 Europe Normothermic Perfusion of Isolated Organs Market Forecast (2026-2032)
6.2 Normothermic Perfusion of Isolated Organs Key Players in Europe
6.3 Europe Normothermic Perfusion of Isolated Organs Market Size by Type
6.4 Europe Normothermic Perfusion of Isolated Organs Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Normothermic Perfusion of Isolated Organs Market Forecast (2026-2032)
7.2 Normothermic Perfusion of Isolated Organs Key Players in Asia-Pacific
7.3 Asia-Pacific Normothermic Perfusion of Isolated Organs Market Size by Type
7.4 Asia-Pacific Normothermic Perfusion of Isolated Organs Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Normothermic Perfusion of Isolated Organs Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Normothermic Perfusion of Isolated Organs Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 TransMedics
9.1.1 TransMedics Company Details
9.1.2 TransMedics Description and Business Overview
9.1.3 TransMedics Normothermic Perfusion of Isolated Organs Introduction
9.1.4 TransMedics Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.1.5 TransMedics Recent Development
9.2 Lung Bioengineering
9.2.1 Lung Bioengineering Company Details
9.2.2 Lung Bioengineering Description and Business Overview
9.2.3 Lung Bioengineering Normothermic Perfusion of Isolated Organs Introduction
9.2.4 Lung Bioengineering Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.2.5 Lung Bioengineering Recent Development
9.3 OrganOx
9.3.1 OrganOx Company Details
9.3.2 OrganOx Description and Business Overview
9.3.3 OrganOx Normothermic Perfusion of Isolated Organs Introduction
9.3.4 OrganOx Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.3.5 OrganOx Recent Development
9.4 XVIVO
9.4.1 XVIVO Company Details
9.4.2 XVIVO Description and Business Overview
9.4.3 XVIVO Normothermic Perfusion of Isolated Organs Introduction
9.4.4 XVIVO Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.4.5 XVIVO Recent Development
9.5 TNO
9.5.1 TNO Company Details
9.5.2 TNO Description and Business Overview
9.5.3 TNO Normothermic Perfusion of Isolated Organs Introduction
9.5.4 TNO Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.5.5 TNO Recent Development
9.6 UHN
9.6.1 UHN Company Details
9.6.2 UHN Description and Business Overview
9.6.3 UHN Normothermic Perfusion of Isolated Organs Introduction
9.6.4 UHN Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.6.5 UHN Recent Development
9.7 SCREEN
9.7.1 SCREEN Company Details
9.7.2 SCREEN Description and Business Overview
9.7.3 SCREEN Normothermic Perfusion of Isolated Organs Introduction
9.7.4 SCREEN Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.7.5 SCREEN Recent Development
9.8 Bridge to Life
9.8.1 Bridge to Life Company Details
9.8.2 Bridge to Life Description and Business Overview
9.8.3 Bridge to Life Normothermic Perfusion of Isolated Organs Introduction
9.8.4 Bridge to Life Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.8.5 Bridge to Life Recent Development
9.9 Organ Recovery Systems
9.9.1 Organ Recovery Systems Company Details
9.9.2 Organ Recovery Systems Description and Business Overview
9.9.3 Organ Recovery Systems Normothermic Perfusion of Isolated Organs Introduction
9.9.4 Organ Recovery Systems Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.9.5 Organ Recovery Systems Recent Development
9.10 Institut Georges Lopez
9.10.1 Institut Georges Lopez Company Details
9.10.2 Institut Georges Lopez Description and Business Overview
9.10.3 Institut Georges Lopez Normothermic Perfusion of Isolated Organs Introduction
9.10.4 Institut Georges Lopez Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.10.5 Institut Georges Lopez Recent Development
9.11 Ebers
9.11.1 Ebers Company Details
9.11.2 Ebers Description and Business Overview
9.11.3 Ebers Normothermic Perfusion of Isolated Organs Introduction
9.11.4 Ebers Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.11.5 Ebers Recent Development
9.12 Penn Medicine
9.12.1 Penn Medicine Company Details
9.12.2 Penn Medicine Description and Business Overview
9.12.3 Penn Medicine Normothermic Perfusion of Isolated Organs Introduction
9.12.4 Penn Medicine Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.12.5 Penn Medicine Recent Development
9.13 Johns Hopkins Medicine
9.13.1 Johns Hopkins Medicine Company Details
9.13.2 Johns Hopkins Medicine Description and Business Overview
9.13.3 Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Introduction
9.13.4 Johns Hopkins Medicine Revenue in Normothermic Perfusion of Isolated Organs Business (2026 & 2032)
9.13.5 Johns Hopkins Medicine Recent Development
10 Normothermic Perfusion of Isolated Organs Market Dynamics
10.1 Normothermic Perfusion of Isolated Organs Industry Trends
10.2 Normothermic Perfusion of Isolated Organs Market Drivers
10.3 Normothermic Perfusion of Isolated Organs Market Challenges
10.4 Normothermic Perfusion of Isolated Organs Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Normothermic Perfusion of Isolated Organs Market Size Growth Rate by Type (2026-2032) & (US$ Million)
Table 2. Key Players of Heart Perfusion
Table 3. Key Players of Liver Perfusion
Table 4. Key Players of Kidney Perfusion
Table 5. Key Players of Lung Perfusion
Table 6. Global Normothermic Perfusion of Isolated Organs Market Size Growth by Application (2026-2032) & (US$ Million)
Table 7. Global Normothermic Perfusion of Isolated Organs Market Size by Region (2026-2032) & (US$ Million)
Table 8. Global Normothermic Perfusion of Isolated Organs Market Size by Region (2026-2032) & (US$ Million)
Table 9. Global Normothermic Perfusion of Isolated Organs Market Share by Region (2026-2032)
Table 10. Market Top Trends
Table 11. Market Use Cases
Table 12. Global Normothermic Perfusion of Isolated Organs Revenue by Players (2026 & 2032) & (US$ Million)
Table 13. Global Normothermic Perfusion of Isolated Organs Market Share by Players (2026 & 2032)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Normothermic Perfusion of Isolated Organs Product/Solution/Service
Table 16. Date of Enter into Normothermic Perfusion of Isolated Organs Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Normothermic Perfusion of Isolated Organs Market Size by Type (2026-2032) & (US$ Million)
Table 19. Global Normothermic Perfusion of Isolated Organs Market Size Share by Type (2026-2032)
Table 20. Global Normothermic Perfusion of Isolated Organs Market Size by Application (2026-2032) & (US$ Million)
Table 21. Global Normothermic Perfusion of Isolated Organs Market Size Share by Application (2026-2032)
Table 22. North America Key Players Normothermic Perfusion of Isolated Organs Revenue (2026 & 2032) & (US$ Million)
Table 23. North America Key Players Normothermic Perfusion of Isolated Organs Market Share (2026 & 2032)
Table 24. North America Normothermic Perfusion of Isolated Organs Market Size by Type (2026-2032) & (US$ Million)
Table 25. North America Normothermic Perfusion of Isolated Organs Market Share by Type (2026-2032)
Table 26. North America Normothermic Perfusion of Isolated Organs Market Size by Application (2026-2032) & (US$ Million)
Table 27. North America Normothermic Perfusion of Isolated Organs Market Share by Application (2026-2032)
Table 28. Europe Key Players Normothermic Perfusion of Isolated Organs Revenue (2026 & 2032) & (US$ Million)
Table 29. Europe Key Players Normothermic Perfusion of Isolated Organs Market Share (2026 & 2032)
Table 30. Europe Normothermic Perfusion of Isolated Organs Market Size by Type (2026-2032) & (US$ Million)
Table 31. Europe Normothermic Perfusion of Isolated Organs Market Share by Type (2026-2032)
Table 32. Europe Normothermic Perfusion of Isolated Organs Market Size by Application (2026-2032) & (US$ Million)
Table 33. Europe Normothermic Perfusion of Isolated Organs Market Share by Application (2026-2032)
Table 34. Asia-Pacific Key Players Normothermic Perfusion of Isolated Organs Revenue (2026 & 2032) & (US$ Million)
Table 35. Asia-Pacific Key Players Normothermic Perfusion of Isolated Organs Market Share (2026 & 2032)
Table 36. Asia-Pacific Normothermic Perfusion of Isolated Organs Market Size by Type (2026-2032) & (US$ Million)
Table 37. Asia-Pacific Normothermic Perfusion of Isolated Organs Market Share by Type (2026-2032)
Table 38. Asia-Pacific Normothermic Perfusion of Isolated Organs Market Size by Application (2026-2032) & (US$ Million)
Table 39. Asia-Pacific Normothermic Perfusion of Isolated Organs Market Share by Application (2026-2032)
Table 40. Key Players in Latin America
Table 41. Key Players in Middle East & Africa
Table 42. TransMedics Company Details
Table 43. TransMedics Description and Business Overview
Table 44. TransMedics Normothermic Perfusion of Isolated Organs Product
Table 45. TransMedics Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 46. TransMedics Recent Development
Table 47. Lung Bioengineering Company Details
Table 48. Lung Bioengineering Description and Business Overview
Table 49. Lung Bioengineering Normothermic Perfusion of Isolated Organs Product
Table 50. Lung Bioengineering Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 51. Lung Bioengineering Recent Development
Table 52. OrganOx Company Details
Table 53. OrganOx Description and Business Overview
Table 54. OrganOx Normothermic Perfusion of Isolated Organs Product
Table 55. OrganOx Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 56. OrganOx Recent Development
Table 57. XVIVO Company Details
Table 58. XVIVO Description and Business Overview
Table 59. XVIVO Normothermic Perfusion of Isolated Organs Product
Table 60. XVIVO Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 61. XVIVO Recent Development
Table 62. TNO Company Details
Table 63. TNO Description and Business Overview
Table 64. TNO Normothermic Perfusion of Isolated Organs Product
Table 65. TNO Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 66. TNO Recent Development
Table 67. UHN Company Details
Table 68. UHN Description and Business Overview
Table 69. UHN Normothermic Perfusion of Isolated Organs Product
Table 70. UHN Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 71. UHN Recent Development
Table 72. SCREEN Company Details
Table 73. SCREEN Description and Business Overview
Table 74. SCREEN Normothermic Perfusion of Isolated Organs Product
Table 75. SCREEN Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 76. SCREEN Recent Development
Table 77. Bridge to Life Company Details
Table 78. Bridge to Life Description and Business Overview
Table 79. Bridge to Life Normothermic Perfusion of Isolated Organs Product
Table 80. Bridge to Life Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 81. Bridge to Life Recent Development
Table 82. Organ Recovery Systems Company Details
Table 83. Organ Recovery Systems Description and Business Overview
Table 84. Organ Recovery Systems Normothermic Perfusion of Isolated Organs Product
Table 85. Organ Recovery Systems Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 86. Organ Recovery Systems Recent Development
Table 87. Institut Georges Lopez Company Details
Table 88. Institut Georges Lopez Description and Business Overview
Table 89. Institut Georges Lopez Normothermic Perfusion of Isolated Organs Product
Table 90. Institut Georges Lopez Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 91. Institut Georges Lopez Recent Development
Table 92. Ebers Company Details
Table 93. Ebers Description and Business Overview
Table 94. Ebers Normothermic Perfusion of Isolated Organs Product
Table 95. Ebers Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 96. Ebers Recent Development
Table 97. Penn Medicine Company Details
Table 98. Penn Medicine Description and Business Overview
Table 99. Penn Medicine Normothermic Perfusion of Isolated Organs Product
Table 100. Penn Medicine Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 101. Penn Medicine Recent Development
Table 102. Johns Hopkins Medicine Company Details
Table 103. Johns Hopkins Medicine Description and Business Overview
Table 104. Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Product
Table 105. Johns Hopkins Medicine Revenue in Normothermic Perfusion of Isolated Organs Business: 2026 & 2032
Table 106. Johns Hopkins Medicine Recent Development
Table 107. Normothermic Perfusion of Isolated Organs Market Trends
Table 108. Normothermic Perfusion of Isolated Organs Market Drivers
Table 109. Normothermic Perfusion of Isolated Organs Market Challenges
Table 110. Normothermic Perfusion of Isolated Organs Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources


List of Figures
Figure 1. Global Normothermic Perfusion of Isolated Organs Market Share by Type in 2026 & 2032
Figure 2. Heart Perfusion Features
Figure 3. Liver Perfusion Features
Figure 4. Kidney Perfusion Features
Figure 5. Lung Perfusion Features
Figure 6. Global Normothermic Perfusion of Isolated Organs Market Share by Application in 2026 & 2032
Figure 7. Organ Transplant Specialist Hospitals Case Studies
Figure 8. Organ Banks Case Studies
Figure 9. Pharmaceutical Research Organizations Case Studies
Figure 10. Normothermic Perfusion of Isolated Organs Report Years Considered
Figure 11. Global Normothermic Perfusion of Isolated Organs Market Size and Growth Rate 2026-2032 (US$ Million)
Figure 12. Global Normothermic Perfusion of Isolated Organs Market Share by Region (2026-2032)
Figure 13. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2026-2032)
Figure 14. North America Normothermic Perfusion of Isolated Organs Market Size 2026-2032 (US$ Million)
Figure 15. Europe Normothermic Perfusion of Isolated Organs Market Size 2026-2032 (US$ Million)
Figure 16. Asia-Pacific Normothermic Perfusion of Isolated Organs Market Size 2026-2032 (US$ Million)
Figure 17. Normothermic Perfusion of Isolated Organs Market Size in Latin America (2026-2032) & (US$ Million)
Figure 18. Normothermic Perfusion of Isolated Organs Market Size in Middle East & Africa (2026-2032) & (US$ Million)
Figure 19. Bottom-up and Top-down Approaches for This Report
Figure 20. Data Triangulation
Figure 21. Key Executives Interviewed